Sign inJoin waitlistJoin the waitlist

PR

Patricia Rich

Physician · Parkview Health

Credentials: · · · · ·

History

Parkview Health
2024–Present

H. Lee Moffitt Cancer Center and Research Institute
2003–2005
Internal Medicine
2000–2003
Univ of Miami Leonard M. Miller Sch of Med
1996–2000

Research

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
Clinical Cancer Research · 2006 · 348 citations
Evaluating intrinsic and non-intrinsic cancer risk factors
Review · Nature Communications · 2018 · 286 citations
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study
Journal of Thoracic Oncology · 2021 · 157 citations

Afshin Dowlati
3 papers
DS
David Spigel
3 papers
Paul Bunn
3 papers
YC
Yuanbin Chen
3 papers
BT
Benjamin Tan
2 papers
Charles Rudin
2 papers
James Gulley
2 papers
MF
Mayer Fishman
2 papers
Scott Antonia
2 papers
Aaron Scott
1 paper
Ajay Bansal
1 paper
Alan Cantor
1 paper

Clinical trials

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2023–2031
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 2, Phase 3
SWOG Cancer Research Network
2019–2029